Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04642352

Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough

Office-Based Superior Laryngeal Nerve (SLN) Block for Treatment of Neurogenic Cough

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate if office-based injection of a local anesthetic/steroid combination at the area of one superior laryngeal nerve can decrease cough frequency and alleviate symptoms of chronic cough in patients with neurogenic cough.

Detailed description

Neurogenic cough is a chronic cough without a clear cause. It is thought to be related to irritation of a nerve that goes to the larynx (voice box). This can happen after a viral upper respiratory infection. Current treatment uses therapy or medications taken by mouth. Those medications can be sedating and not well tolerated. An alternative approach would be to perform an injection "nerve block", which is commonly done for other nerve disorders such as around the spine. This may help people with neurogenic cough also. We studied this recently in a small group of patients and found that patients had improvement in their cough symptoms (Simpson 2018). It would be helpful to study this in a larger group of patients using more methods of evaluating cough symptom severity.

Conditions

Interventions

TypeNameDescription
DRUGsuperior laryngeal nerve blockA unilateral injection of 2 cc of a 1:1 mixture of 0.25% bupivacaine and Kenalog-40 via a 27 gauge needle to the thyrohyoid space (front of neck, just above larynx/voice box) via a 27 gauge needle to the thyrohyoid space (front of neck, just above larynx/voice box) on the side which exhibited most discomfort/tenderness/cough on palpation. If neither side was uncomfortable, the right side will be used.

Timeline

Start date
2022-01-03
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2020-11-24
Last updated
2025-02-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04642352. Inclusion in this directory is not an endorsement.